移植市場：製品別、用途別、エンドユーザー別、地域別、2024-2032年

世界の移植市場規模は2023年に160億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて8.39%の成長率（CAGR）を示し、2032年までに336億米ドルに達すると予測しています。同市場は、医療技術の急速な進歩、慢性疾患の増加、臓器提供を推進する政府や非政府組織（NGO）によるイニシアチブの高まり、専門的な移植センターの拡大、医療政策や保険適用範囲の進化などによって大きな成長を遂げています。

移植市場の分析：

市場の成長と規模急速な技術進歩、慢性疾患の増加、医療政策の改善などにより、市場は安定した成長を遂げています。

主な市場促進要因：市場成長に影響を与える主な促進要因は、医療技術の急速な進歩、慢性疾患による臓器不全の発生率の上昇、移植センターの拡大、政府による支援策、医療政策の進化などです。

主要市場動向：主な市場動向としては、個別化移植医療へのシフトの進行、バイオエンジニアリングによる臓器・組織の使用が挙げられます。また、新たな免疫抑制剤や保存療法を開発するための研究開発（R&D）への投資が増加していることも、市場の成長を後押ししています。

地理的動向：北米は、先進的な医療システム、高い移植率、強力な臓器提供ネットワークによって市場をリードしています。その他の地域も、医療インフラの改善と消費者の意識の高まりに後押しされ、大きな伸びを示しています。

競合情勢：同市場は、戦略的な合併、買収、提携を行い、製品ポートフォリオの拡充と世界のプレゼンス拡大に注力する主要企業が積極的に関与しているのが特徴です。さらに各社は、薬剤製剤、組織工学、臓器保存技術の革新に向けた研究開発（R&D）への投資に注力しています。

課題と機会：同市場は、臓器提供者不足への対応、臓器提供をめぐる倫理的問題、地域による医療アクセスの格差など、さまざまな課題に直面しています。しかし、組織工学の進歩や、移植医療への公平なアクセスを支援する政策の策定が、市場成長の新たな機会を生み出しています。

移植市場の動向：

移植技術の急速な進歩

移植の成功率と患者の予後を改善する手術技術、免疫抑制薬、臓器保存における絶え間ない進歩と革新が、市場成長に明るい見通しを生み出しています。これに伴い、回復時間と合併症を軽減する最小侵襲（MI）手術法の市場開拓が進み、それによって臓器移植の実現可能性と人気が高まっていることが、市場成長にプラスの影響を与えています。さらに、臓器拒絶反応のリスクを最小限に抑える組織タイピングとマッチングの急速な進歩が、市場の成長を促進しています。これとともに、より正確で迅速な臓器マッチング、患者の転帰予測、移植後のケア管理のための移植におけるデジタルおよび人工知能（AI）技術の統合が市場成長を強化しています。

慢性疾患と臓器不全の有病率の増加

糖尿病、高血圧、心臓病などの慢性疾患の有病率が上昇し、臓器移植の必要性が高まっていることは、市場成長を促進する主な要因の1つです。これに伴い、糖尿病や高血圧に起因する腎不全の発生率が増加し、世界中で腎臓移植の需要が高まっていることが、市場の成長を後押ししています。これとともに、心臓病や肝臓病の診断が増加し、心臓移植や肝臓移植の必要性に拍車がかかっていることも、成長を促す要因となっています。これに加えて、臓器不全につながる慢性疾患にかかりやすい老年人口の増加が、市場に明るい見通しをもたらしています。さらに、さまざまな健康状態に対する意識の高まりと診断の向上が、移植を必要とする患者の早期発見を容易にし、市場成長の触媒となっています。

政府および非政府組織（NGO）による臓器提供推進イニシアチブの高まり

臓器提供を推進する政府や非政府組織（NGO）の影響力の高まりは、市場成長にプラスの影響を与えています。これに伴い、臓器提供者数の増加につながる啓発キャンペーン、臓器提供手続きの簡素化、支援法制の組織化が増加しており、市場成長に好影響を与えています。これに加えて、臓器提供プロセスを合理化するための政府やNGOと医療プロバイダーとの連携が急増していることも、市場の成長を刺激しています。これとともに、臓器提供プロセスに家族の同意を含める政策の導入や全国ドナー登録の確立が、市場成長の起爆剤となっています。さらに、臓器提供のベストプラクティスやリソースを共有し、世界の移植ネットワークを強化するための国際協力の普及が進んでいることも、市場の成長を支えています。

移植センターとサービスの拡大

世界中で専門的な移植センターとサービスが増加し、拡大していることが、市場の成長を後押ししています。専門の移植センターは、複雑な移植手術を実施できる高度な設備と熟練した専門家を備えています。これに伴い、治療を必要とする患者数の増加に対応し、移植サービスへの幅広いアクセスを確保する専用センターの設立が、市場の成長を後押ししています。さらに、移植前のカウンセリング、高度な外科手術、移植後のフォローアップとリハビリテーションを含む包括的なケアを提供する、専門的な移植と個別ケアにセンターが重点を置くようになったことも、市場成長に弾みをつけています。さらに、農村部や十分な医療が行き届いていない地域へのセンターの拡大により、より幅広い層の人々が移植サービスを受けやすくなっていることも、市場成長の原動力となっています。

医療政策と保険適用の拡大

資金援助、償還政策、保険適用など、移植手術を支援するさまざまな政府医療イニシアチブの導入は、市場成長を大幅に後押ししています。これとともに、さまざまな医療システムで移植の手順と費用を標準化する取り組みが増加していることも、市場の成長を後押ししています。これに加えて、免疫抑制剤の投与や拒絶反応や合併症の兆候の定期的なモニタリングなど、長期的な術後ケアの費用をカバーする医療サービスの統合が、市場の成長を後押ししています。これに加えて、政策立案者が異なる社会経済グループ、民族、地域間の移植率の格差に対処するため、移植サービスへのアクセスにおける公平性に注目が集まっていることも、市場の成長を後押ししています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要産業動向

第5章 世界の移植市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品別

• 組織製品
  • 市場動向
  • 市場予測
• 免疫抑制剤
  • 市場動向
  • 市場予測
• 保存液
  • 市場動向
  • 市場予測

第7章 市場内訳：用途別

• 臓器移植
  • 市場動向
  • 市場予測
• 組織移植
  • 市場動向
  • 市場予測

第8章 市場内訳：エンドユーザー別

• 病院
  • 市場動向
  • 市場予測
• 移植センター
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第9章 市場内訳：地域別

• 北米
  • 米国
    • 市場動向
    • 市場予測
  • カナダ
    • 市場動向
    • 市場予測
• アジア太平洋
  • 中国
    • 市場動向
    • 市場予測
  • 日本
    • 市場動向
    • 市場予測
  • インド
    • 市場動向
    • 市場予測
  • 韓国
    • 市場動向
    • 市場予測
  • オーストラリア
    • 市場動向
    • 市場予測
  • インドネシア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測
• 欧州
  • ドイツ
    • 市場動向
    • 市場予測
  • フランス
    • 市場動向
    • 市場予測
  • 英国
    • 市場動向
    • 市場予測
  • イタリア
    • 市場動向
    • 市場予測
  • スペイン
    • 市場動向
    • 市場予測
  • ロシア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測
• ラテンアメリカ
  • ブラジル
    • 市場動向
    • 市場予測
  • メキシコ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測
• 中東・アフリカ地域
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第10章 促進要因、抑制要因、機会

• 市場概要
• 促進要因
• 抑制要因
• 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • 21st Century Medicine
  • AbbVie Inc.
  • Arthrex Inc.
  • Astellas Pharma Inc.
  • BioLife Solutions Inc.
  • CareDx Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • TransMedics Inc.
  • Veloxis Pharmaceutical Inc.（Asahi Kasei Corporation）

List of Figures

• Figure 1: Global: Transplantation Market: Major Drivers and Challenges
• Figure 2: Global: Transplantation Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Transplantation Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Transplantation Market: Breakup by Product (in %), 2023
• Figure 5: Global: Transplantation Market: Breakup by Application (in %), 2023
• Figure 6: Global: Transplantation Market: Breakup by End User (in %), 2023
• Figure 7: Global: Transplantation Market: Breakup by Region (in %), 2023
• Figure 8: Global: Transplantation (Tissue Products) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 9: Global: Transplantation (Tissue Products) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 10: Global: Transplantation (Immunosuppressive Drugs) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 11: Global: Transplantation (Immunosuppressive Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 12: Global: Transplantation (Preservation Solution) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Transplantation (Preservation Solution) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 14: Global: Transplantation (Organ Transplantation) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 15: Global: Transplantation (Organ Transplantation) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 16: Global: Transplantation (Tissue Transplantation) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: Transplantation (Tissue Transplantation) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 18: Global: Transplantation (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: Transplantation (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Transplantation (Transplantation Centers) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Transplantation (Transplantation Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 22: Global: Transplantation (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 23: Global: Transplantation (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 24: North America: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 25: North America: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 26: United States: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 27: United States: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 28: Canada: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 29: Canada: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: Asia-Pacific: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: Asia-Pacific: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 32: China: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 33: China: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 34: Japan: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 35: Japan: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 36: India: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: India: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: South Korea: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: South Korea: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: Australia: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: Australia: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: Indonesia: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: Indonesia: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: Others: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: Others: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: Europe: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 47: Europe: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 48: Germany: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 49: Germany: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 50: France: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 51: France: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 52: United Kingdom: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 53: United Kingdom: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 54: Italy: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 55: Italy: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 56: Spain: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 57: Spain: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 58: Russia: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 59: Russia: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 60: Others: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 61: Others: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 62: Latin America: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 63: Latin America: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Brazil: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 65: Brazil: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 66: Mexico: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 67: Mexico: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Others: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 69: Others: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 70: Middle East and Africa: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
• Figure 71: Middle East and Africa: Transplantation Market: Breakup by Country (in %), 2023
• Figure 72: Middle East and Africa: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 73: Global: Transplantation Industry: Drivers, Restraints, and Opportunities
• Figure 74: Global: Transplantation Industry: Value Chain Analysis
• Figure 75: Global: Transplantation Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Transplantation Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Transplantation Market Forecast: Breakup by Product (in Million US$), 2024-2032
• Table 3: Global: Transplantation Market Forecast: Breakup by Application (in Million US$), 2024-2032
• Table 4: Global: Transplantation Market Forecast: Breakup by End User (in Million US$), 2024-2032
• Table 5: Global: Transplantation Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: Transplantation Market: Competitive Structure
• Table 7: Global: Transplantation Market: Key Players

Abstract

The global transplantation market size reached US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.6 Billion by 2032, exhibiting a growth rate (CAGR) of 8.39% during 2024-2032. The market is experiencing significant growth driven by rapid advancements in medical technologies, increasing prevalence of chronic diseases, rising initiatives by government and non-governmental organization (NGO) promoting organ donation, expansion of specialized transplantation centers, and the evolving healthcare policies and insurance coverage.

Transplantation Market Analysis:

Market Growth and Size: The market is witnessing stable growth, driven by rapid technological advancements, increasing prevalence of chronic disease, and improved healthcare policies.

Major Market Drivers: Key drivers influencing the market growth include rapid advancements in medical technologies, rising incidence of organ failure due to chronic diseases, expansion of transplantation centers, supportive initiatives by government, and evolving healthcare policies.

Key Market Trends: The key market trends involve the ongoing shift towards personalized transplantation medicine and the use of bio-engineered organs and tissues. Additionally, the increasing investment in research and development (R&D) for developing new immunosuppressive drugs and preservation solutions, is bolstering the market growth.

Geographical Trends: North America leads the market due to its advanced healthcare system, high transplantation rates, and strong organ donation networks. Other regions are also showing significant growth, fueled by the improving healthcare infrastructure and rising consumer awareness.

Competitive Landscape: The market is characterized by the active involvement of key players that are engaged in strategic mergers, acquisitions, and partnerships, focusing on expanding their product portfolios and global presence. Furthermore, companies are focusing on investing in research and development (R&D) to innovate in drug formulations, tissue engineering, and organ preservation technologies.

Challenges and Opportunities: The market faces various challenges, such as managing the organ donor shortage, ethical issues surrounding organ donation, and disparities in healthcare access across different regions. However, advancements in tissue engineering and development of policies to support equitable access to transplant services, are creating new opportunities for the market growth.

Transplantation Market Trends:

Rapid advancements in transplantation technologies

The continuous advancements and innovations in surgical techniques, immunosuppressive medications, and organ preservation that improve transplant success rates and patient outcomes are creating a positive outlook for the market growth. In line with this, the development of minimal invasive (MI) surgical methods to reduce recovery times and complications, thereby increasing the feasibility and popularity of organ transplants is positively impacting the market growth. Moreover, rapid advancements in tissue typing and matching that minimize the risk of organ rejection are fostering the market growth. Along with this, the integration of digital and artificial intelligence (AI) technologies in transplantation for more accurate and quicker organ matching, predicting patient outcomes, and managing post-transplant care is strengthening the market growth.

Increasing prevalence of chronic diseases and organ failure

The rising prevalence of chronic diseases, such as diabetes, hypertension, and heart disease, leading to an increased need for organ transplants, is one of the major factors driving the market growth. In line with this, the growing incidence of kidney failure due to diabetes and hypertension, escalating the demand for kidney transplants across the globe, is providing a thrust to the market growth. Along with this, the increasing diagnosis of heart and liver diseases, spurring the need for heart and liver transplants, is acting as a growth-inducing factor. Besides this, the growing geriatric population who are susceptible to chronic diseases leading to organ failure is creating a positive outlook for the market. Furthermore, the heightened awareness and improved diagnosis of various health conditions, facilitating early identification of patients that require transplants, is catalyzing the market growth.

Rising initiatives by government and non-governmental organizations (NGOs) to promote organ donation

The growing influence of governments and non-governmental organizations (NGOs) in promoting organ donation is positively impacting the market growth. In line with this, the increasing organization of awareness campaigns, simplified donation procedures, and supportive legislation, leading to a rise in the number of organ donors, is favoring the market growth. Besides this, the burgeoning collaboration of the government and NGOs with healthcare providers to streamline the organ donation process is stimulating the market growth. Along with this, the introduction of policies that include family consent in the donation process and the establishment of national donor registries are catalyzing the market growth. Additionally, the heightened prevalence of international collaborations to share best practices and resources in organ donation and strengthen the global transplantation network is supporting the market growth.

Expansion of transplantation centers and services

The rising growth and expansion of specialized transplantation centers and services across the globe are providing a thrust to the market growth. The specialized transplantation centers are equipped with advanced facilities and skilled professionals capable of performing complex transplant procedures. In line with this, the establishment of dedicated centers that ensure wider accessibility to transplantation services, catering to the growing patient population requiring treatment, is boosting the market growth. Additionally, the heightened focus of the centers on specialized transplants and personalized care, offering comprehensive care that includes pre-transplant counseling, advanced surgical procedures, and post-transplant follow-up and rehabilitation, is providing an impetus to the market growth. Furthermore, the expansion of the centers to rural and underserved areas, making transplantation services more accessible to a broader segment of the population, is catalyzing the market growth.

Growing healthcare policies and insurance coverage

The introduction of various government healthcare initiatives that support transplantation procedures, including funding, reimbursement policies, and insurance coverage, is providing a considerable boost to the market growth. Along with this, the increasing efforts to standardize transplant procedures and costs across various healthcare systems are also favoring the market growth. Besides this, the integration of health services that cover the cost of long-term post-operative care, including immunosuppressive medications and regular monitoring for any signs of rejection or complications, is enhancing the market growth. In addition to this, the increasing focus on equity in access to transplant services as policymakers address disparities in transplantation rates among different socio-economic groups, ethnicities, and regions is fueling the market growth.

Transplantation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and end user.

Breakup by Product:

Tissue Products

Immunosuppressive Drugs

Preservation Solution

Tissue products account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes tissue products, immunosuppressive drugs, and preservation solution. According to the report, tissue products represented the largest segment.

Tissue products represent the largest segment in the market due to the high demand for various types of tissues such as corneas, skin, heart valves, bones, and veins. They are employed in a broad range of applications, such as ophthalmic procedures and orthopedic and reconstructive surgeries. Moreover, rapid technological advancements in tissue engineering and grafting techniques are positively impacting the market growth. Additionally, the increasing incidence of conditions requiring tissue transplants, such as burns, trauma, and degenerative diseases, is providing an impetus to the market growth.

Immunosuppressive drugs are essential in transplantation to prevent organ rejection and maintain the long-term viability of the transplant. They include a variety of medications, such as calcineurin inhibitors, corticosteroids, anti-proliferative agents, and mTOR inhibitors. Furthermore, the continuous research and development (R&D) to improve the efficacy of the drugs while minimizing their side effects, is favoring the market growth.

Preservation solutions are critical for maintaining the viability of organs and tissues from the time of donation to transplantation. They are designed to reduce ischemic damage to organs and extend their shelf-life, which is crucial for facilitating transplants over longer distances and improving the overall success rate of transplant surgeries.

Breakup by Application:

Organ Transplantation

Tissue Transplantation

Tissue transplantation holds the largest share in the industry

A detailed breakup and analysis of the transplantation market based on the application has also been provided in the report. This includes organ transplantation and tissue transplantation. According to the report, tissue transplantation accounted for the largest market share.

Tissue transplantation holds the largest market share, as it includes a broad range of procedures, such as skin, corneas, heart valves, bones, and veins. The widespread need for tissue transplantation in various medical conditions and procedures, including burn treatments, reconstructive surgeries, and ophthalmic conditions, is creating a positive outlook for the market growth. Moreover, the increasing prevalence of chronic diseases, accidents, and age-related degenerative conditions, escalating the demand for tissue transplants, is favoring the market growth. In addition to this, rapid advances in tissue engineering and regenerative medicine that improve the outcomes of transplants are catalyzing the market growth.

Organ transplantation involves the transplantation of vital organs, such as the heart, liver, kidney, and lungs. It is driven by the critical need for organ replacements in patients with end-stage organ failure resulting from chronic diseases like diabetes, hypertension, and cardiac diseases. Organ transplantation is characterized by its high complexity and the critical nature of the procedures. The success of organ transplantation heavily depends on timely donor matching, effective immunosuppression to prevent rejection, and advanced surgical techniques.

Breakup by End User:

Hospitals

Transplantation Centers

Others

Hospitals represent the leading market segment

The report has provided a detailed breakup and analysis of the transplantation market based on the end user. This includes hospitals, transplantation centers, and others. According to the report, hospitals represented the largest segment.

Hospitals represent the largest market segment due to their comprehensive healthcare services and the ability to facilitate a wide range of transplant procedures. The dominance of hospitals is attributed to their extensive infrastructure, which includes advanced surgical facilities, intensive care units (ICUs), and specialized transplant departments. Hospitals are the first point of contact for patients requiring transplants, offering services, such as initial diagnosis, evaluation, and post-transplant care. They are equipped to handle complex transplant surgeries and provide comprehensive care, including pre-operative preparation and post-operative monitoring. Additionally, hospitals have larger patient inflows, giving them a broader base for potential transplant candidates.

Transplantation centers are exclusively focused on transplant procedures and providing highly specialized care. They consist of teams of experts who are specifically trained in various aspects of transplantation, including surgeons, transplant coordinators, immunologists, and rehabilitation specialists. Transplantation centers are known for their expertise in handling complex cases and offering cutting-edge treatments, including experimental procedures and clinical trials.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest transplantation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America leads the transplantation market due to its advanced healthcare infrastructure, high healthcare expenditure, and robust organ donation and transplantation programs. Moreover, the region benefits from a strong presence of leading healthcare companies and research institutions that contribute to the development of innovative transplantation technologies and drugs. Furthermore, North America has one of the highest rates of organ transplantation across the globe, supported by comprehensive regulatory frameworks and a well-organized network of organ procurement organizations. Additionally, the region's focus on research and development (R&D), coupled with favorable government policies and initiatives promoting organ donation, is driving the market growth.

Europe's transplantation market is characterized by advanced healthcare systems and high standards of medical care. Furthermore, the region has a strong network of transplantation centers and a well-established regulatory framework governing organ donation and transplantation. Moreover, the increasing government funding in healthcare, the growing prevalence of chronic diseases requiring transplants, and ongoing research in transplantation medicine are favoring the market growth.

The Asia Pacific region is experiencing rapid growth in the transplantation market, fueled by the increasing prevalence of chronic diseases, improvements in healthcare infrastructure, and rising healthcare expenditures. Additionally, the growing public awareness about organ donation and government initiatives to regulate and promote organ transplantation are contributing to the market growth.

Latin America's transplantation market is growing, driven by several factors, such as the improving healthcare systems and increasing government initiatives to support organ transplantation. Moreover, rapid advancements in transplantation procedures, leading to better outcomes and post-surgery results, are creating a positive outlook for the market growth.

The Middle East and Africa region has seen substantial growth in the transplantation market due to the increasing investments in healthcare infrastructure and growing awareness about transplantation. Additionally, the rising interest in establishing more specialized transplantation centers to address regional needs and improve access to transplant care in the region is favoring the market growth.

Leading Key Players in the Transplantation Industry:

The key players are engaged in a range of strategic activities to strengthen their positions and address the growing demands of the market. They are heavily investing in research and development (R&D) to innovate in areas like immunosuppressive drugs, organ preservation solutions, and bio-engineered tissues. Furthermore, major players are involved in mergers and acquisitions, partnerships with healthcare providers, and collaborations with academic and research institutions to expand their market reach and enhance their product portfolios. Besides this, they are also engaging in initiatives to raise public awareness about organ donation and are involved in policy advocacy to improve transplantation-related healthcare policies.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

21st Century Medicine

AbbVie Inc.

Arthrex Inc.

Astellas Pharma Inc.

BioLife Solutions Inc.

CareDx Inc.

Novartis AG

Teva Pharmaceutical Industries Ltd.

TransMedics Inc.

Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)

Latest News:

In January 2022, Novartis AG announced a collaboration with Alnylam for exploring targeted therapy to restore liver function with the help of Alnylam's siRNA.

In January 2022, BioLife Solutions extended its collaboration with Seattle Children 's Therapeutics to optimize and enhance biopreservation and closed-system manufacturing by integrating Sexton's AF-500 cell processing tools.

In December 2022, AbbVie Inc. announced its strategic partnership with HotSpot Therapeutics to develop its pipeline for immunology products.

Key Questions Answered in This Report

• 1. How big is the global transplantation market?
• 2. What is the expected growth rate of the global transplantation market during 2024-2032?
• 3. What are the key factors driving the global transplantation market?
• 4. What has been the impact of COVID-19 on the global transplantation market?
• 5. What is the breakup of the global transplantation market based on the product?
• 6. What is the breakup of the global transplantation market based on the application?
• 7. What is the breakup of the global transplantation market based on the end user?
• 8. What are the key regions in the global transplantation market?
• 9. Who are the key players/companies in the global transplantation market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Transplantation Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Tissue Products
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Immunosuppressive Drugs
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Preservation Solution
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Organ Transplantation
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Tissue Transplantation
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Transplantation Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 21st Century Medicine
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 AbbVie Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Arthrex Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 SWOT Analysis
  • 14.3.4 Astellas Pharma Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 BioLife Solutions Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
  • 14.3.6 CareDx Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Novartis AG
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Teva Pharmaceutical Industries Ltd.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 TransMedics Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio